{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:20:47Z","timestamp":1785831647274,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["2019-41"],"award-info":[{"award-number":["2019-41"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bulcan.2021.01.026","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T08:15:57Z","timestamp":1629792957000},"page":"908-914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-8160","authenticated-orcid":false,"given":"Marianne","family":"Veyri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Lavol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Choquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Solas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Poizot-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9939","key":"10.1016\/j.bulcan.2021.01.026_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bulcan.2021.01.026_bib0120","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Antiretroviral Therapy Cohort Collaboration","year":"2017","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.bulcan.2021.01.026_bib0125","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies","volume":"50","author":"Antiretroviral Therapy Cohort Collaboration","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.bulcan.2021.01.026_bib0130","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/QAD.0b013e328353f38e","article-title":"Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods","volume":"26","author":"Simard","year":"2012","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.bulcan.2021.01.026_bib0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study","volume":"14","author":"Weber","year":"2013","journal-title":"HIV Med"},{"issue":"9581","key":"10.1016\/j.bulcan.2021.01.026_bib0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.026_bib0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2021.01.026_bib0150","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.bulcan.2021.01.026_bib0155","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.bulcan.2021.01.026_bib0160","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/cid\/cix392","article-title":"Cancer-attributable mortality among people with treated human immunodeficiency virus infection in North America","volume":"65","author":"Engels","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bulcan.2021.01.026_bib0165","series-title":"New malignancies among cancer survivors: SEER Cancer Registries, 1973\u20132000","year":"2006"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.026_bib0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","article-title":"Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors","volume":"10","author":"Travis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"21","key":"10.1016\/j.bulcan.2021.01.026_bib0175","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2021.01.026_bib0180","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1055-9965.EPI-14-1079","article-title":"Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers","volume":"24","author":"Marcus","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.bulcan.2021.01.026_bib0185","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/S2352-3018(18)30179-6","article-title":"Incidence of first and second primary cancers diagnosed among people with HIV, 1985\u20132013: a population-based, registry-linkage study","volume":"5","author":"Hessol","year":"2018","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.026_bib0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12032-018-1224-2","article-title":"HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH Group","volume":"36","author":"Gobert","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.bulcan.2021.01.026_bib0195","series-title":"Estimation du risque de second cancer en France\/\u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim, les donn\u00e9es, avril 2015","author":"J\u00e9gu","year":"2015"},{"issue":"19","key":"10.1016\/j.bulcan.2021.01.026_bib0200","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.30164","article-title":"Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008","volume":"122","author":"Donin","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2021.01.026_bib0205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","article-title":"Prevalence of prior cancer among persons newly diagnosed with cancer: an initial report from the surveillance, epidemiology, and end results program","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2021.01.026_bib0210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/QAD.0b013e328352d1ad","article-title":"HIV as an independent risk factor for incident lung cancer","volume":"26","author":"Sigel","year":"2012","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.bulcan.2021.01.026_bib0215","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/QAD.0000000000000283","article-title":"Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV","volume":"28","author":"Helleberg","year":"2014","journal-title":"AIDS"},{"issue":"16","key":"10.1016\/j.bulcan.2021.01.026_bib0220","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0000000000001996","article-title":"Secondary anal cancer prevention in the HIV-infected: a step ahead but a long way to go","volume":"32","author":"Schim van der Loeff","year":"2018","journal-title":"AIDS"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:20:02Z","timestamp":1762104002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121002824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0007455121002824"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.01.026","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}